Submit Manuscript  

Article Details


NGS of microRNAs Involved in Cardioprotection Induced by Sevoflurane Compared to Propofol in Myocardial Revascularization Surgery: The ACDHUVV-16 Clinical Trial

Author(s):

Jose Luis Guerrero Orriach*, Juan Jose Escalona Belmonte, Marta Ramirez Aliaga, Alicia Ramirez Fernandez, Maria Jose Rodriguez Capitan, Guillermo Quesada Muñoz, Aida Raigón Ponferrada, Juan Alcaide Torres, Concepcion Santiago-Fernandez, Emilio Matute Gonzalez, Manuel Rubio Navarro, Rocio Bautista, Josefa Gómez Maldonado, Lourdes Garrido-Sanchez and Jose Cruz Mañas   Pages 1 - 12 ( 12 )

Abstract:


Background: Numerous studies have demonstrated that halogenated agents elicit myocardial conditioning effects when adminis-tered perioperatively in cardiac surgery. Recent evidence has been published of the benefits of maintaining exposure to halogenated agents during the early postoperative period. The enzymatic mechanisms by which this beneficial effect is exerted were explained recently.

Objectives: Our study was performed to investigate whether this phenomenon is mediated by either the activation or suppression of miR-NAs targeted by halogenated anesthetics.

Methods: A double-blind, two-stage trial was conducted. The results of the first stage of the trial are presented in this paper. The sample was composed of patients undergoing off-pump myocardial revascularization surgery. Patients were randomized to receive either sevoflu-rane [S] or propofol [P] during the intraoperative and early postoperative period (during the first six hours after the intervention). Hemody-namics (heart rate, blood pressure, central venous pressure, cardiac index, systolic volume index, LVEF) and myocardial enzymes (troponin I) were monitored at six hour intervals during the first 48 hours. In the first stage of the trial, blood was drawn for gene sequencing from eight patients (four per group) at baseline and at 24 h. In the second stage of the study, a qPCR analysis was performed of the miRNAs identified as significant by gene sequencing. Levels of cardioprotective enzymes (serine/threonine protein kinase (Akt), tumor necrosis fac-tor alpha (TNFα), extracellular regulated protein kinase (ERK 1/2), and caspase 3) were measured to assess their role in myocardial condi-tioning pathways. The purpose was to identify the miRNAs that play a major role in myocardial conditioning induced by halogenated agents. Concentrations of cardioprotective enzymes were higher in patients who received sevoflurane, as compared to patients who were administered propofol.

Results: NGS differences were observed between baseline and 24-h values in the two study groups. In group P, miRNA 197-3p was over-expressed, whereas miRNAs 4443 and 1294, 708-3p were underexpressed. In group S, miRNAs 615-3p, 4466, 29, 937-3p, 636, 197-3P, 184, 4685, 296-3p, 147b, 3199, 6815, 1294 and 3176 were underexpressed; whereas 708-3p was overexpressed. qPCR showed significant variations in miRNAs 197-3p, 4443, 708-3p and 1294 in the P group, and in miRNAs 937-3p, 636, 197-3p, 296-3p and 708-3p in the S group.

Conclusions: In the P Group, changes in the expression of some miRNAs were associated with lower concentrations of the enzymes in-volved in myocardial pre- and postconditioning. In contrast, in Group S, variations in miRNAs were associated with the activation of medi-ators of anesthetic-induced pre- and post-conditioning, a reduction in cell apoptosis, and a decrease in caspase and TnBF alpha concentra-tions. Changes in these miRNAs were associated with a better prognosis in patients with ischemic heart disease. The main limitation of this study will be overcome in the second stage of the trial, where the specific role of each miRNA will be determined.

Keywords:

miRNAs, cardiac anesthesia, preconditioning, postconditioning, aconditioning, halogenated.

Affiliation:

Department of Cardio-Anaesthesiology, University Hospital Virgen de la Victoria, Málaga,, Instituto de Investigacion Biomédica de Málaga (IBIMA), Málaga,, Department of Cardio-Anaesthesiology, University Hospital Virgen de la Victoria, Málaga,, Instituto de Investigacion Biomédica de Málaga (IBIMA), Málaga,, Department of Cardio-Anaesthesiology, University Hospital Virgen de la Victoria, Málaga,, Instituto de Investigacion Biomédica de Málaga (IBIMA), Málaga,, Department of Cardio-Anaesthesiology, University Hospital Virgen de la Victoria, Málaga,, Unidad de Gestión Clínica de Endocrinología y Nutrición, Hospital Universitario Virgen de la Victoria, Málaga,, Unidad de Gestión Clínica de Endocrinología y Nutrición, Hospital Universitario Virgen de la Victoria, Málaga,, Department of Anesthesia, Hospital Universitario, Sanitas La Moraleja,, Department of Cardio-Anaesthesiology, University Hospital Virgen de la Victoria, Málaga,, Genómic and Ultrasecuenciation. Supercomputación y Bioinno-vación Center, Malaga University, Malaga,, Genómic and Ultrasecuenciation. Supercomputación y Bioinno-vación Center, Malaga University, Malaga,, CIBER Fisiopatología de la Obesidad y Nutrición-CIBEROBN, Instituto de Salud, Carlos III,, Department of Cardio-Anaesthesiology, University Hospital Virgen de la Victoria, Málaga



Read Full-Text article